Smoking and diabetes
Annales d'Endocrinologie · 2024
DOI: 10.1016/j.ando.2024.08.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales d'Endocrinologie, 2024. Verfasst von Alexia Rouland und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolic Diseases, CHU Dijon, Dijon, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Smoking, Smoking Cessation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Sante publique France.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Smoking increases insulin resistance via multiple mechanisms but is a poorly understood risk factor for onset of type-2 diabetes. It is also associated with impaired beta-cell function in humans, but again the mechanisms are poorly understood. Mechanistic studies of the impact of smoking on carbohydrate metabolism mainly evaluated nicotine as the causal agent, and more rarely other tobacco constituents, making it impossible to conclude that the risk of diabetes is linked to the effects of nicotine alone. Active smoking also has negative impact on glycemic control in both type-1 and type-2 diabetic patients. It increases the risk of all-cause mortality and worsens the chronic complications of diabetes. Impact on microangiopathic complications in type-2 diabetic patients, however, is more controversial. Data on pharmacological and behavioral strategies for smoking cessation used in the general population are more sparse in diabetic patients, despite opportunities with recent therapeutic trials involving varenicline and GLP-1 analogues. It is essential for diabetic patients to stop smoking, and diabetologists must get involved in smoking cessation as they have done for many years in therapeutic education, which can easily include measures to help patients stop smoking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetology and Metabolic Diseases, CHU Dijon, Dijon, France.
- Department of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Brest, Brest, France. Electronic address: philippe.thuillier@chu-brest.fr.
- Department of Endocrinology, Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France; PeriTox=UMR-I 01, University of Picardy Jules-Verne, Amiens, France.
- Cognition Health and Society Laboratory (C2S-EA 6291), University of Reims Champagne-Ardenne, Reims, France; Department of Psychiatry, Marne Public Mental Health Institute & Reims University Hospital, Reims, France.
- Department of Endocrinology and Diabetology, Strasbourg University Hospital, Strasbourg, France; Institute of Cellular and Integrative Neuroscience, CNRS UPR-3212, Strasbourg, France.
- Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.
Förderung
- Sante publique France
Zitieren
APA
Rouland, A., Thuillier, P., Al-Salameh, A., Benzerouk, F., Bahougne, T., Tramunt, B., Berlin, I., Clair, C., Thomas, D., Le Faou, A. L., Vergès, B., & Durlach, V. (2024). Smoking and diabetes. Annales d'Endocrinologie. https://doi.org/10.1016/j.ando.2024.08.001
Vancouver
Rouland A, Thuillier P, Al-Salameh A, Benzerouk F, Bahougne T, Tramunt B, et al. Smoking and diabetes. Annales d'Endocrinologie. 2024. doi:10.1016/j.ando.2024.08.001
BibTeX
@article{Rouland2024,
author = {Rouland, Alexia and Thuillier, Philippe and Al-Salameh, Abdallah and Benzerouk, Farid and Bahougne, Thibault and Tramunt, Blandine and Berlin, Ivan and Clair, Carole and Thomas, Daniel and Le Faou, Anne-Laurence and Vergès, Bruno and Durlach, Vincent},
title = {Smoking and diabetes},
journal = {Annales d'Endocrinologie},
year = {2024},
doi = {10.1016/j.ando.2024.08.001}
}
EUVIMED